IL6 and Hypercholesterolemia: Patients with elevated IL-6 (Group 2) were more likely to present with diabetes mellitus (64.3% vs. 41.7%; p = 0.046) and hypercholesterolemia (76.2% vs. 58.2% p = 0.03).